-
2025 Peking University Urology Academic Forum | Prof. Tianxin Lin (Sun Yat-sen Memorial Hospital of Sun Yat-sen University)
Prof. Tianxin Lin delivered an insightful presentation on the application of artificial intelligence in the precision diagnosis and treatment of bladder cancer. He highlighted the current diagnostic challenges related to…
-
ASCO 2025 High-Level Dialogue | Prof. Kohei Shitara: New Breakthroughs with T-DXd and CAR-T Cell Therapy Reshape Outcomes in Advanced Gastric Cancer
At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, two studies in the field of targeted therapy for gastric cancer drew significant attention. The world’s first randomized controlled trial (RCT) of CAR-T cell therapy for solid tumors (Abstract 4003) reported positive results, demonstrating both superior efficacy and manageable safety for Claudin 18.2-targeted CAR-T…
-
N Engl J Med | Dr. Jun Shi’s Team Reports First Successful Use of BCMA-Targeted Bispecific T-Cell Engager to Rescue Relapsed Autoimmune Hemolytic Anemia After CD19 CAR T-Cell Therapy
Autoimmune hemolytic anemia (AIHA) has a relatively high incidence (1.8–3.0 per 100,000 person-years) and prevalence (17 per 100,000), with a substantial proportion of patients experiencing refractory or relapsed disease. Nearly 50% of patients relapse multiple times despite receiving first-line glucocorticoids, second-line CD20 monoclonal antibodies, and multiple conventional immunosuppressants, often becoming dependent on long-term drug therapy.…
Connecting Medical Expertise through Media
